4-phenylbutyric acid has been researched along with mexiletine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alvarez-López, M; Amorós, I; Barana, A; Caballero, R; Delpón, E; Dolz-Gaitón, P; González de la Fuente, M; Jiménez-Jáimez, J; Macías-Ruiz, R; Matamoros, M; Núñez, L; Núñez, M; Pérez-Hernández, M; Tamargo, J; Tercedor-Sánchez, L | 1 |
1 review(s) available for 4-phenylbutyric acid and mexiletine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for 4-phenylbutyric acid and mexiletine
| Article | Year |
|---|---|
Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1.5 channel underlying a Brugada syndrome with variable expression in a Spanish family.
Topics: Biological Transport; Brugada Syndrome; Female; Frameshift Mutation; Humans; Mexiletine; Middle Aged; NAV1.5 Voltage-Gated Sodium Channel; Phenylbutyrates | 2013 |